December 14, 2012 / 6:46 AM / 5 years ago

Fresenius to quit biotech unit

FRANKFURT, Dec 14 (Reuters) - German healthcare group Fresenius said it would exit its loss-making biotech business in order to focus on its other businesses, which it said offer better growth opportunities.

Fresenius said it was in talks with several parties over a sale of Fresenius Biotech, which had sales of 26 million euros ($34 million) in the first nine months of 2012 but posted a loss of 15 million euros.

$1 = 0.7641 euros Reporting by Victoria Bryan

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below